Author

A. Torres-Reveron

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:clinical cohort / trial· 1 Organism:human· 1 Organism:rat· 1

Frequent Co-Authors

C. B. Appleyard· 1 shared I. Flores· 1 shared L. L. Rivera-Lopez· 1 shared M. J. Serra-Torres· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

C. B. Appleyard

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Retrospective analysis of the use of osteoporosis medication at the presentation of fragility fractures in a predominantly Hispanic population.

A. Torres-Reveron, M. J. Serra-Torres

The paper examines osteoporosis medication use in a Hispanic population with fragility fractures, finding 42% received prophylactic treatment, with higher rates linked to age and insurance.

bioRxiv · Dec 24, 2020Pharmacology & Toxicology

Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis.

A. Torres-Reveron, L. L. Rivera-Lopez, I. Flores, C. B. Appleyard

This study shows that blocking CRHR1 with antalarmin reduces endometriosis progression in rats by decreasing vesicle size and number.

bioRxiv · May 8, 2018Physiology